REGENERX BIOPHARMACEUTICALS, INC. Total Contract Liability
REGENERX BIOPHARMACEUTICALS, INC. had Total Contract Liability of $1.95 million as of 2022-12-31, per its 10-K filed 2023-04-11.
Discontinued › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2023-04-11
- 2022-12-31: Contract with Customer, Liability $1.95M.
- 2021-12-31: Contract with Customer, Liability $2.02M.
- 2020-12-31: Contract with Customer, Liability $2.10M.
- 2019-12-31: Contract with Customer, Liability $2.18M.
| Period end | Contract with Customer, Liability |
|---|---|
| 2022-12-31 | $1.95M 10-K · filed 2023-04-11 |
| 2021-12-31 | $2.02M 10-K · filed 2023-04-11 |
| 2020-12-31 | $2.10M 10-K · filed 2023-04-11 |
| 2019-12-31 | $2.18M 10-K · filed 2021-03-02 |
| 2018-12-31 | $2.25M 10-K · filed 2020-03-20 |